Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]

Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] was reported 117950 times

Drugs of the Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 SENSITISATION 159 0.2095
1 EJECTION FRACTION 117 0.2014
2 ENCEPHALITIS HERPES 92 0.1862
3 SMOOTH MUSCLE CELL NEOPLASM 69 0.1651
4 OPHTHALMIC HERPES SIMPLEX 82 0.1424
5 ENGRAFTMENT SYNDROME 76 0.1286
6 LIGHT CHAIN ANALYSIS INCREASED 128 0.1239
7 URINE LEUKOCYTE ESTERASE POSITIVE 79 0.1129
8 URINARY SEDIMENT PRESENT 66 0.1025
9 POLYCYSTIC OVARIES 159 0.1024
10 RED BLOOD CELLS URINE POSITIVE 98 0.1013
11 FUSARIUM INFECTION 68 0.0971
12 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 117 0.0828
13 PLASMACYTOMA 154 0.0827
14 PLASMA CELL MYELOMA RECURRENT 268 0.0824
15 MONOCLONAL IMMUNOGLOBULIN PRESENT 62 0.0816
16 VARICELLA ZOSTER VIRUS INFECTION 165 0.0795
17 ENCEPHALITIS VIRAL 94 0.0772
18 GRAFT VERSUS HOST DISEASE 550 0.0764
19 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 204 0.0737
20 ACUTE GRAFT VERSUS HOST DISEASE 321 0.0701
21 NEUTROPHIL PERCENTAGE INCREASED 87 0.0689
22 PLASMA CELL MYELOMA 2649 0.0678
23 TOXOPLASMOSIS 73 0.0676
24 LYMPHOCYTE PERCENTAGE DECREASED 90 0.0670
25 CYTOMEGALOVIRUS TEST POSITIVE 119 0.0667
26 ENTEROCOCCAL BACTERAEMIA 70 0.0660
27 PARAINFLUENZAE VIRUS INFECTION 100 0.0657
28 GRAFT VERSUS HOST DISEASE IN SKIN 140 0.0635
29 SYSTEMIC MYCOSIS 74 0.0634
30 EJECTION FRACTION ABNORMAL 77 0.0628
31 STEM CELL TRANSPLANT 157 0.0628
32 PNEUMONIA CYTOMEGALOVIRAL 119 0.0612
33 CYTOKINE RELEASE SYNDROME 1216 0.0606
34 HERPES SIMPLEX 385 0.0592
35 CHRONIC GRAFT VERSUS HOST DISEASE 212 0.0587
36 PLASMA CELL MYELOMA REFRACTORY 77 0.0575
37 WHITE BLOOD CELLS URINE POSITIVE 108 0.0574
38 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 122 0.0573
39 CULTURE URINE POSITIVE 80 0.0569
40 ACUTE MYELOID LEUKAEMIA RECURRENT 122 0.0568
41 FULL BLOOD COUNT DECREASED 1109 0.0550
42 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 72 0.0547
43 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 318 0.0536
44 ASPERGILLOSIS 70 0.0536
45 FULL BLOOD COUNT INCREASED 63 0.0529
46 NEPHRECTOMY 78 0.0525
47 SYSTEMIC CANDIDA 131 0.0521
48 HERPES OPHTHALMIC 67 0.0507
49 CYTOMEGALOVIRUS INFECTION REACTIVATION 224 0.0507
50 CYTOMEGALOVIRUS VIRAEMIA 224 0.0503
51 PNEUMONIA FUNGAL 198 0.0501
52 PSEUDOMONAL SEPSIS 86 0.0491
53 GENITAL HERPES 74 0.0483
54 EPSTEIN-BARR VIRUS INFECTION 302 0.0483
55 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 246 0.0483
56 POST HERPETIC NEURALGIA 68 0.0473
57 APLASTIC ANAEMIA 245 0.0469
58 HUMAN HERPESVIRUS 6 INFECTION 86 0.0455
59 MUCORMYCOSIS 118 0.0454
60 OBSTRUCTIVE SLEEP APNOEA SYNDROME 66 0.0452
61 CYTOMEGALOVIRUS CHORIORETINITIS 88 0.0451
62 BACTERIAL SEPSIS 146 0.0448
63 RHINITIS ALLERGIC 199 0.0447
64 HERPES VIRUS INFECTION 257 0.0446
65 BONE MARROW TRANSPLANT 84 0.0443
66 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 114 0.0441
67 VENOOCCLUSIVE LIVER DISEASE 217 0.0439
68 FEBRILE NEUTROPENIA 2905 0.0437
69 ESCHERICHIA BACTERAEMIA 101 0.0429
70 CYTOMEGALOVIRUS INFECTION 712 0.0428
71 ENTEROCOCCAL INFECTION 207 0.0428
72 TOXIC ENCEPHALOPATHY 215 0.0424
73 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 75 0.0424
74 LEUKAEMIA RECURRENT 71 0.0420
75 FUNGAEMIA 66 0.0419
76 CYSTITIS HAEMORRHAGIC 168 0.0416
77 ADENOVIRUS INFECTION 120 0.0413
78 NEUROTOXICITY 724 0.0413
79 NEUTROPHIL COUNT ABNORMAL 116 0.0410
80 BRONCHOPULMONARY ASPERGILLOSIS 313 0.0403
81 OSTEOLYSIS 82 0.0401
82 MULTIPLE MYELOMA 186 0.0399
83 VENOOCCLUSIVE DISEASE 99 0.0395
84 HYPOGAMMAGLOBULINAEMIA 259 0.0394
85 URINE ABNORMALITY 177 0.0389
86 BACTERIAL TEST POSITIVE 86 0.0385
87 TUMOUR LYSIS SYNDROME 333 0.0378
88 BONE LESION 136 0.0377
89 PNEUMONIA VIRAL 120 0.0376
90 URINE ANALYSIS ABNORMAL 111 0.0371
91 ENCEPHALITIS 255 0.0368
92 CYTOPENIA 443 0.0361
93 STAPHYLOCOCCAL BACTERAEMIA 156 0.0359
94 NEUTROPENIC SEPSIS 241 0.0337
95 ACUTE MYELOID LEUKAEMIA 525 0.0337
96 BLOOD IMMUNOGLOBULIN G DECREASED 83 0.0335
97 BACTERAEMIA 397 0.0334
98 RHINOVIRUS INFECTION 128 0.0329
99 MUCOSAL INFLAMMATION 857 0.0327
100 APLASIA 63 0.0321
101 NEUTROPHIL COUNT DECREASED 1293 0.0317
102 CHRONIC LYMPHOCYTIC LEUKAEMIA 150 0.0316
103 LYMPHOCYTE COUNT DECREASED 558 0.0315
104 CLOSTRIDIUM DIFFICILE COLITIS 330 0.0311
105 COVID-19 PNEUMONIA 367 0.0311
106 NEUTROPENIC COLITIS 64 0.0309
107 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 228 0.0304
108 ACUTE LYMPHOCYTIC LEUKAEMIA 86 0.0303
109 BK VIRUS INFECTION 102 0.0302
110 WHITE BLOOD CELL COUNT DECREASED 3269 0.0301
111 ESCHERICHIA SEPSIS 87 0.0300
112 CAPILLARY LEAK SYNDROME 62 0.0300
113 PLATELET COUNT DECREASED 3149 0.0295
114 HYPERPARATHYROIDISM SECONDARY 74 0.0295
115 NEPHROGENIC ANAEMIA 134 0.0289
116 RED CELL DISTRIBUTION WIDTH INCREASED 119 0.0286
117 VARICELLA 68 0.0284
118 NEUROPATHY PERIPHERAL 2692 0.0283
119 LABORATORY TEST ABNORMAL 828 0.0280
120 STAPHYLOCOCCAL SEPSIS 138 0.0279
121 HOSPICE CARE 274 0.0277
122 RESPIRATORY TRACT INFECTION VIRAL 64 0.0275
123 PANCYTOPENIA 1527 0.0273
124 NEPHROPATHY TOXIC 302 0.0269
125 LACTOSE INTOLERANCE 68 0.0265
126 PROTEIN TOTAL INCREASED 69 0.0259
127 HISTIOCYTOSIS HAEMATOPHAGIC 76 0.0256
128 ENCEPHALOPATHY 628 0.0255
129 RED BLOOD CELL COUNT DECREASED 730 0.0255
130 MULTIPLE ORGAN DYSFUNCTION SYNDROME 723 0.0255
131 RESPIRATORY SYNCYTIAL VIRUS INFECTION 221 0.0254
132 WHITE BLOOD CELL DISORDER 67 0.0250
133 BLOOD CULTURE POSITIVE 74 0.0247
134 BLOOD TEST ABNORMAL 347 0.0247
135 ASPERGILLUS INFECTION 161 0.0245
136 PATHOGEN RESISTANCE 223 0.0244
137 NEUTROPENIA 3317 0.0244
138 HYPERBILIRUBINAEMIA 252 0.0243
139 KLEBSIELLA INFECTION 123 0.0243
140 FIBRIN D DIMER INCREASED 86 0.0242
141 SQUAMOUS CELL CARCINOMA OF SKIN 144 0.0238
142 BONE MARROW DISORDER 72 0.0238
143 PROTEIN TOTAL DECREASED 89 0.0236
144 HERPES ZOSTER 1355 0.0236
145 SEPTIC SHOCK 1026 0.0236
146 PLEURITIC PAIN 65 0.0235
147 THROMBOTIC MICROANGIOPATHY 229 0.0235
148 ATELECTASIS 226 0.0234
149 RENAL TUBULAR DISORDER 65 0.0231
150 HYPERURICAEMIA 94 0.0228
151 LUNG INFILTRATION 201 0.0227
152 FULL BLOOD COUNT ABNORMAL 240 0.0227
153 DIFFUSE LARGE B-CELL LYMPHOMA 174 0.0226
154 THROMBOCYTOPENIA 2509 0.0224
155 TOXIC EPIDERMAL NECROLYSIS 337 0.0222
156 REBOUND ACID HYPERSECRETION 67 0.0221
157 LYMPHOPENIA 313 0.0221
158 PSEUDOMONAS INFECTION 189 0.0220
159 VITAMIN B12 DECREASED 63 0.0218
160 PATHOLOGICAL FRACTURE 108 0.0213
161 HORDEOLUM 91 0.0210
162 IMMUNE THROMBOCYTOPENIA 96 0.0209
163 MULTIPLE ALLERGIES 164 0.0209
164 PNEUMONIA BACTERIAL 191 0.0208
165 BLOOD PHOSPHORUS DECREASED 75 0.0205
166 SEPSIS 2287 0.0205
167 PLATELET COUNT ABNORMAL 123 0.0203
168 MENINGITIS ASEPTIC 91 0.0202
169 HAEMATOTOXICITY 192 0.0202
170 IMMUNOSUPPRESSION 178 0.0202
171 ESCHERICHIA URINARY TRACT INFECTION 85 0.0200
172 MULTIPLE-DRUG RESISTANCE 62 0.0200
173 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 76 0.0199
174 RASH VESICULAR 96 0.0198
175 BLOOD CREATININE DECREASED 62 0.0198
176 HAEMATOCRIT DECREASED 388 0.0195
177 SPLENOMEGALY 228 0.0194
178 APLASIA PURE RED CELL 66 0.0192
179 SEASONAL ALLERGY 271 0.0191
180 ORAL HERPES 372 0.0190
181 BLOOD UREA INCREASED 319 0.0190
182 COMPRESSION FRACTURE 102 0.0190
183 WHITE BLOOD CELL COUNT ABNORMAL 121 0.0189
184 SERUM FERRITIN INCREASED 100 0.0189
185 FAILURE TO THRIVE 98 0.0189
186 ESCHERICHIA INFECTION 155 0.0188
187 TRANSFUSION 197 0.0188
188 PULMONARY THROMBOSIS 205 0.0188
189 TOOTH DISORDER 418 0.0188
190 HYPERCALCAEMIA 232 0.0188
191 PNEUMOCYSTIS JIROVECII PNEUMONIA 188 0.0187
192 MULTI-ORGAN FAILURE 323 0.0187
193 BLOOD LACTATE DEHYDROGENASE INCREASED 296 0.0187
194 AUTOIMMUNE HAEMOLYTIC ANAEMIA 64 0.0187
195 RENAL FAILURE ACUTE 790 0.0186
196 BLOOD ALBUMIN DECREASED 146 0.0184
197 BLOOD BILIRUBIN INCREASED 496 0.0183
198 LEUKAEMIA 172 0.0182
199 ENTEROCOLITIS 105 0.0182
200 VASCULAR DEVICE INFECTION 82 0.0181
201 ATRIAL FLUTTER 144 0.0180
202 DISSEMINATED INTRAVASCULAR COAGULATION 254 0.0180
203 DRUG RESISTANCE 459 0.0179
204 HYPOPHOSPHATAEMIA 132 0.0178
205 PNEUMONIA 5776 0.0178
206 CARPAL TUNNEL SYNDROME 249 0.0178
207 BLOOD CALCIUM DECREASED 199 0.0177
208 RENAL TUBULAR NECROSIS 173 0.0176
209 HYPOALBUMINAEMIA 137 0.0176
210 MYELODYSPLASTIC SYNDROME 254 0.0175
211 ACUTE RESPIRATORY FAILURE 337 0.0175
212 HYPOXIA 616 0.0175
213 CLOSTRIDIUM DIFFICILE INFECTION 379 0.0173
214 TASTE DISORDER 352 0.0173
215 BLOOD CREATININE INCREASED 1124 0.0172
216 BLOOD POTASSIUM DECREASED 517 0.0172
217 MONOCYTE COUNT INCREASED 62 0.0171
218 ACUTE KIDNEY INJURY 2612 0.0171
219 MENINGITIS 113 0.0169
220 CANDIDA INFECTION 285 0.0169
221 SPINAL COMPRESSION FRACTURE 139 0.0168
222 HYPERVOLAEMIA 83 0.0168
223 SPINAL OSTEOARTHRITIS 147 0.0167
224 BLOOD MAGNESIUM DECREASED 144 0.0167
225 BACTERIAL INFECTION 311 0.0167
226 IMMUNODEFICIENCY 248 0.0166
227 HAEMODIALYSIS 139 0.0165
228 PERFORMANCE STATUS DECREASED 77 0.0165
229 THROMBOSIS 1318 0.0164
230 HYPOKALAEMIA 756 0.0164
231 HAEMOGLOBIN DECREASED 1679 0.0163
232 DEEP VEIN THROMBOSIS 1059 0.0163
233 PERIPHERAL SENSORY NEUROPATHY 95 0.0162
234 VIRAL UPPER RESPIRATORY TRACT INFECTION 77 0.0162
235 AGEUSIA 401 0.0161
236 ACUTE RESPIRATORY DISTRESS SYNDROME 284 0.0160
237 RASH MACULO-PAPULAR 356 0.0160
238 CANDIDIASIS 64 0.0159
239 ORTHOSTATIC HYPOTENSION 277 0.0159
240 MENTAL STATUS CHANGES 441 0.0159
241 STATUS EPILEPTICUS 178 0.0157
242 INCREASED TENDENCY TO BRUISE 145 0.0157
243 BENIGN PROSTATIC HYPERPLASIA 81 0.0157
244 STAPHYLOCOCCAL INFECTION 513 0.0155
245 BODY HEIGHT DECREASED 166 0.0155
246 TRANSPLANT REJECTION 124 0.0155
247 FEBRILE BONE MARROW APLASIA 65 0.0153
248 BLOOD COUNT ABNORMAL 231 0.0152
249 SKIN ABRASION 72 0.0152
250 PROTEIN URINE PRESENT 75 0.0150
251 RESPIRATORY FAILURE 1096 0.0150
252 MUSCULOSKELETAL CHEST PAIN 232 0.0150
253 HICCUPS 123 0.0150
254 BLOOD CREATINE INCREASED 66 0.0149
255 PETECHIAE 154 0.0147
256 RENAL DISORDER 687 0.0147
257 ORAL DISORDER 108 0.0147
258 PARTIAL SEIZURES 77 0.0147
259 BONE MARROW FAILURE 298 0.0146
260 PYREXIA 5071 0.0146
261 PULMONARY ALVEOLAR HAEMORRHAGE 82 0.0146
262 BLOOD URIC ACID INCREASED 84 0.0145
263 UPPER RESPIRATORY TRACT INFECTION 670 0.0145
264 LEFT VENTRICULAR HYPERTROPHY 62 0.0145
265 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 112 0.0144
266 SINUS TACHYCARDIA 204 0.0144
267 HAEMOGLOBIN ABNORMAL 91 0.0141
268 ALTERED STATE OF CONSCIOUSNESS 306 0.0141
269 DERMATITIS BULLOUS 102 0.0141
270 BLOOD THYROID STIMULATING HORMONE DECREASED 64 0.0141
271 OSTEOPENIA 213 0.0140
272 STREPTOCOCCAL INFECTION 78 0.0140
273 CONSTIPATION 3031 0.0139
274 LEUKOPENIA 693 0.0138
275 PLEURAL EFFUSION 843 0.0138
276 HYPERNATRAEMIA 69 0.0138
277 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 356 0.0138
278 SLEEP APNOEA SYNDROME 264 0.0138
279 ANAEMIA 2630 0.0138
280 GINGIVITIS 74 0.0137
281 NEPHROPATHY 128 0.0137
282 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 113 0.0137
283 ATRIAL FIBRILLATION 1327 0.0136
284 ODYNOPHAGIA 81 0.0136
285 RENAL FAILURE 1800 0.0135
286 PERICARDIAL EFFUSION 313 0.0135
287 PULMONARY HAEMORRHAGE 105 0.0134
288 INFUSION SITE EXTRAVASATION 83 0.0133
289 HEPATITIS B 80 0.0133
290 RALES 77 0.0132
291 VITAMIN D DECREASED 113 0.0132
292 OLIGURIA 82 0.0132
293 IMMUNE SYSTEM DISORDER 174 0.0132
294 TACHYPNOEA 179 0.0132
295 ECCHYMOSIS 90 0.0131
296 END STAGE RENAL DISEASE 239 0.0131
297 CELLULITIS 660 0.0131
298 HYPOMAGNESAEMIA 182 0.0131
299 ASPARTATE AMINOTRANSFERASE INCREASED 693 0.0130
300 POLYNEUROPATHY 156 0.0130
301 C-REACTIVE PROTEIN INCREASED 472 0.0130
302 STOMATITIS 779 0.0128
303 ALANINE AMINOTRANSFERASE INCREASED 787 0.0128
304 RENAL IMPAIRMENT 1070 0.0127
305 DEVICE RELATED INFECTION 196 0.0127
306 BLOOD URINE PRESENT 241 0.0127
307 HYDRONEPHROSIS 95 0.0127
308 SPINAL FRACTURE 254 0.0127
309 ORAL CANDIDIASIS 166 0.0126
310 BLOOD ALKALINE PHOSPHATASE INCREASED 313 0.0126
311 FUNGAL INFECTION 418 0.0125
312 SKIN LESION 344 0.0125
313 LUNG INFECTION 194 0.0125
314 HYPERTRANSAMINASAEMIA 86 0.0124
315 URINE OUTPUT DECREASED 108 0.0123
316 BODY TEMPERATURE INCREASED 252 0.0123
317 PAPULE 87 0.0123
318 RESPIRATORY TRACT INFECTION 320 0.0123
319 GASTROINTESTINAL INFECTION 110 0.0123
320 NECROSIS 68 0.0122
321 HYPOTHYROIDISM 389 0.0122
322 BASAL CELL CARCINOMA 190 0.0122
323 RASH PRURITIC 660 0.0122
324 SINUS BRADYCARDIA 117 0.0121
325 MALNUTRITION 135 0.0121
326 TOOTH INFECTION 159 0.0120
327 RESPIRATORY DISTRESS 332 0.0120
328 CHRONIC KIDNEY DISEASE 914 0.0120
329 PNEUMONITIS 327 0.0120
330 HAEMORRHAGE INTRACRANIAL 179 0.0120
331 BLOOD SODIUM DECREASED 225 0.0119
332 SUBDURAL HAEMATOMA 169 0.0118
333 GENERALISED OEDEMA 146 0.0118
334 DRUG LEVEL INCREASED 195 0.0118
335 DIARRHOEA 7593 0.0118
336 INFECTION 1700 0.0117
337 INTERVERTEBRAL DISC DEGENERATION 108 0.0117
338 LYMPHADENOPATHY 413 0.0117
339 SINUS DISORDER 230 0.0116
340 HEPATOMEGALY 114 0.0116
341 PULMONARY OEDEMA 519 0.0116
342 RIB FRACTURE 238 0.0116
343 ENTERITIS 74 0.0116
344 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 196 0.0115
345 VIRAL INFECTION 384 0.0115
346 HEPATIC CYTOLYSIS 147 0.0115
347 PULMONARY MASS 171 0.0115
348 HYPOCALCAEMIA 216 0.0114
349 SPINAL DISORDER 108 0.0114
350 ACIDOSIS 87 0.0114
351 BACK DISORDER 185 0.0114
352 EYE INFECTION 128 0.0113
353 DIVERTICULITIS 312 0.0112
354 GAMMA-GLUTAMYLTRANSFERASE INCREASED 247 0.0111
355 DISEASE PROGRESSION 1316 0.0111
356 TRICUSPID VALVE INCOMPETENCE 88 0.0111
357 HYPOPHAGIA 283 0.0111
358 STEVENS-JOHNSON SYNDROME 246 0.0111
359 BLOOD CALCIUM INCREASED 97 0.0110
360 HEPATOTOXICITY 246 0.0110
361 ONYCHOCLASIS 76 0.0110
362 ANURIA 95 0.0110
363 DEHYDRATION 1470 0.0110
364 HAEMOLYSIS 85 0.0110
365 INFUSION SITE SWELLING 69 0.0110
366 CARDIAC FAILURE ACUTE 73 0.0109
367 BRAIN OEDEMA 138 0.0109
368 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 104 0.0109
369 CORONAVIRUS INFECTION 72 0.0109
370 LEUKOCYTOSIS 197 0.0109
371 WHITE BLOOD CELL COUNT INCREASED 417 0.0109
372 GOUT 195 0.0109
373 SUPRAVENTRICULAR TACHYCARDIA 104 0.0109
374 TUBULOINTERSTITIAL NEPHRITIS 203 0.0108
375 GINGIVAL PAIN 86 0.0108
376 COVID-19 1885 0.0107
377 PURPURA 95 0.0107
378 MITRAL VALVE INCOMPETENCE 121 0.0107
379 BRONCHITIS 791 0.0107
380 BONE DISORDER 194 0.0106
381 FATIGUE 8287 0.0106
382 SINUSITIS 1090 0.0106
383 PROCTALGIA 68 0.0106
384 DECUBITUS ULCER 86 0.0105
385 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 108 0.0105
386 UROSEPSIS 97 0.0105
387 SWELLING OF EYELID 66 0.0105
388 TOOTH ABSCESS 107 0.0105
389 ELECTROLYTE IMBALANCE 122 0.0105
390 NEURALGIA 255 0.0105
391 MUSCLE SPASMS 1924 0.0105
392 PERIPHERAL SWELLING 1614 0.0105
393 PULMONARY EMBOLISM 994 0.0104
394 INFLUENZA 1166 0.0104
395 ATAXIA 124 0.0104
396 BONE PAIN 611 0.0104
397 TRANSAMINASES INCREASED 230 0.0103
398 HYPERLIPIDAEMIA 123 0.0103
399 HYPERGLYCAEMIA 375 0.0103
400 CATARACT 612 0.0103
401 RENAL FAILURE CHRONIC 79 0.0103
402 ORAL PAIN 228 0.0102
403 URINARY TRACT INFECTION 1734 0.0102
404 OSTEOMYELITIS 184 0.0102
405 HEPATITIS ACUTE 66 0.0101
406 SARS-COV-2 TEST POSITIVE 134 0.0101
407 DECREASED APPETITE 2355 0.0101
408 RASH 4412 0.0101
409 BRAIN FOG 158 0.0101
410 TENDERNESS 105 0.0101
411 RENAL CYST 80 0.0101
412 MYOCLONUS 120 0.0101
413 CARDIOMEGALY 123 0.0100
414 LARGE INTESTINE POLYP 69 0.0100
415 AGRANULOCYTOSIS 185 0.0099
416 COLITIS 375 0.0099
417 OESOPHAGITIS 108 0.0099
418 HYPONATRAEMIA 556 0.0099
419 NEUTROPHIL COUNT INCREASED 101 0.0099
420 VITAMIN D DEFICIENCY 96 0.0098
421 ILEUS 122 0.0098
422 FACIAL PAIN 87 0.0097
423 THERAPY PARTIAL RESPONDER 152 0.0097
424 ANHEDONIA 256 0.0097
425 OEDEMA 528 0.0097
426 SKIN INFECTION 109 0.0097
427 OEDEMA PERIPHERAL 1184 0.0097
428 HAEMODYNAMIC INSTABILITY 74 0.0097
429 DRUG TOXICITY 132 0.0097
430 CONFUSIONAL STATE 1565 0.0097
431 PHOTOPHOBIA 182 0.0097
432 SMALL INTESTINAL OBSTRUCTION 119 0.0097
433 ASCITES 283 0.0096
434 FACIAL PARALYSIS 82 0.0096
435 HEPATIC FAILURE 290 0.0096
436 HAEMOLYTIC ANAEMIA 86 0.0096
437 PRODUCT DISTRIBUTION ISSUE 89 0.0096
438 DIZZINESS POSTURAL 93 0.0096
439 HAEMOPTYSIS 267 0.0096
440 SQUAMOUS CELL CARCINOMA 90 0.0096
441 LEFT VENTRICULAR DYSFUNCTION 64 0.0095
442 LOCALISED INFECTION 231 0.0095
443 NERVOUS SYSTEM DISORDER 298 0.0095
444 MOUTH HAEMORRHAGE 70 0.0095
445 HYPOTENSION 1915 0.0095
446 ERYTHEMA MULTIFORME 89 0.0095
447 GASTROENTERITIS 139 0.0095
448 CHILLS 1110 0.0095
449 UPPER-AIRWAY COUGH SYNDROME 78 0.0095
450 GASTROOESOPHAGEAL REFLUX DISEASE 762 0.0095
451 TOXIC SKIN ERUPTION 95 0.0094
452 DIVERTICULUM 67 0.0094
453 EMBOLISM 78 0.0094
454 NIGHT SWEATS 302 0.0094
455 WEIGHT FLUCTUATION 98 0.0094
456 DELIRIUM 325 0.0094
457 DRUG ERUPTION 165 0.0093
458 APHASIA 281 0.0093
459 GALLBLADDER DISORDER 166 0.0093
460 LIVER FUNCTION TEST ABNORMAL 270 0.0093
461 PHARYNGITIS 115 0.0093
462 PROTEINURIA 176 0.0092
463 FIBROMYALGIA 225 0.0092
464 DEPRESSED LEVEL OF CONSCIOUSNESS 366 0.0092
465 DERMATITIS ALLERGIC 116 0.0092
466 FLUID OVERLOAD 134 0.0092
467 SECOND PRIMARY MALIGNANCY 76 0.0091
468 DENTAL CARIES 101 0.0091
469 ASTHENIA 3427 0.0091
470 CHOLESTASIS 175 0.0091
471 VASCULITIS 106 0.0091
472 SCAB 103 0.0090
473 HYPOAESTHESIA 1351 0.0090
474 RESPIRATORY TRACT CONGESTION 143 0.0090
475 DISORIENTATION 356 0.0090
476 CHOLECYSTITIS 107 0.0090
477 ECONOMIC PROBLEM 136 0.0090
478 HAEMORRHOIDS 175 0.0090
479 SKIN DISCOLOURATION 412 0.0090
480 TOOTHACHE 162 0.0089
481 LYMPHOMA 138 0.0089
482 DYSPNOEA EXERTIONAL 335 0.0089
483 LIPASE INCREASED 68 0.0089
484 MASS 124 0.0089
485 BLOOD POTASSIUM INCREASED 144 0.0089
486 GINGIVAL BLEEDING 121 0.0089
487 HALLUCINATION, VISUAL 187 0.0088
488 FLANK PAIN 83 0.0088
489 SPINAL PAIN 103 0.0088
490 EPISTAXIS 657 0.0088
491 NO THERAPEUTIC RESPONSE 107 0.0088
492 ARTHROPOD BITE 65 0.0088
493 INFUSION SITE PAIN 113 0.0088
494 DERMATITIS CONTACT 100 0.0088
495 RASH GENERALISED 227 0.0088
496 COAGULOPATHY 146 0.0088
497 EOSINOPHIL COUNT INCREASED 73 0.0088
498 FLUID RETENTION 444 0.0087
499 FURUNCLE 69 0.0087
500 MOUTH ULCERATION 183 0.0087
501 MUSCLE STRAIN 75 0.0087
502 VENTRICULAR EXTRASYSTOLES 90 0.0087
503 PERIPHERAL COLDNESS 119 0.0087
504 PRODUCT ADMINISTRATION INTERRUPTED 68 0.0087
505 EYE PAIN 485 0.0086
506 MYOPATHY 74 0.0086
507 LIVER DISORDER 378 0.0085
508 HYPOAESTHESIA ORAL 128 0.0085
509 NOCTURIA 103 0.0085
510 ADVERSE DRUG REACTION 761 0.0085
511 SKIN LACERATION 92 0.0085
512 NERVE INJURY 94 0.0084
513 CONJUNCTIVITIS 156 0.0084
514 TACHYCARDIA 746 0.0084
515 HIP FRACTURE 270 0.0084
516 CYSTITIS 267 0.0084
517 HAEMATURIA 287 0.0084
518 EAR DISCOMFORT 86 0.0084
519 NASOPHARYNGITIS 1543 0.0084
520 GASTROENTERITIS VIRAL 151 0.0084
521 BACK PAIN 1940 0.0083
522 BLOOD IRON DECREASED 99 0.0083
523 LIMB DISCOMFORT 258 0.0083
524 EXOSTOSIS 76 0.0083
525 GLOMERULAR FILTRATION RATE DECREASED 102 0.0083
526 ROTATOR CUFF SYNDROME 106 0.0082
527 GASTRITIS 217 0.0082
528 OSTEONECROSIS OF JAW 204 0.0082
529 RASH MACULAR 287 0.0082
530 LIVER FUNCTION TEST INCREASED 176 0.0082
531 UNEVALUABLE EVENT 619 0.0082
532 TORSADE DE POINTES 64 0.0081
533 GENERALISED TONIC-CLONIC SEIZURE 135 0.0081
534 HEPATIC FUNCTION ABNORMAL 304 0.0081
535 CONTUSION 784 0.0081
536 DIARRHOEA HAEMORRHAGIC 76 0.0081
537 APHTHOUS ULCER 63 0.0081
538 DRY EYE 405 0.0081
539 CHROMATURIA 183 0.0081
540 DYSARTHRIA 304 0.0081
541 ARTERIOSCLEROSIS 76 0.0081
542 HYPERKALAEMIA 283 0.0081
543 PNEUMOTHORAX 127 0.0080
544 TOOTH FRACTURE 88 0.0080
545 SKIN DISORDER 266 0.0080
546 RASH PAPULAR 178 0.0079
547 FEELING COLD 221 0.0079
548 PAIN IN JAW 224 0.0079
549 SKIN CANCER 170 0.0079
550 BALANCE DISORDER 681 0.0079
551 BLOOD DISORDER 63 0.0079
552 SUBARACHNOID HAEMORRHAGE 80 0.0078
553 BRADYCARDIA 413 0.0078
554 EJECTION FRACTION DECREASED 121 0.0078
555 SINUS CONGESTION 105 0.0078
556 THERAPY NON-RESPONDER 349 0.0078
557 SKIN ULCER 200 0.0077
558 PULMONARY CONGESTION 102 0.0077
559 RHINORRHOEA 500 0.0077
560 LIMB INJURY 210 0.0077
561 COGNITIVE DISORDER 360 0.0077
562 PNEUMONIA ASPIRATION 192 0.0077
563 ACUTE HEPATIC FAILURE 105 0.0077
564 PRODUCTIVE COUGH 366 0.0077
565 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 367 0.0076
566 OROPHARYNGEAL PAIN 705 0.0076
567 EYE DISCHARGE 79 0.0076
568 RESPIRATORY DISORDER 227 0.0076
569 GRAND MAL CONVULSION 70 0.0076
570 MUSCULAR WEAKNESS 861 0.0076
571 CENTRAL NERVOUS SYSTEM LESION 104 0.0076
572 LOWER RESPIRATORY TRACT INFECTION 344 0.0076
573 COUGH 2120 0.0076
574 CEREBRAL HAEMORRHAGE 269 0.0075
575 HEART RATE DECREASED 263 0.0075
576 TREMOR 1241 0.0075
577 OFF LABEL USE 6540 0.0075
578 SWELLING FACE 486 0.0075
579 INFUSION RELATED REACTION 494 0.0074
580 SYNCOPE 745 0.0074
581 DYSURIA 274 0.0074
582 OSTEOPOROSIS 306 0.0074
583 EAR PAIN 144 0.0074
584 CARDIAC MURMUR 64 0.0074
585 WOUND INFECTION 81 0.0074
586 OCULAR DISCOMFORT 83 0.0074
587 APPENDICITIS 69 0.0074
588 POLLAKIURIA 308 0.0074
589 CARDIAC DISORDER 690 0.0074
590 RENAL INJURY 219 0.0074
591 BLISTER 414 0.0074
592 IRON DEFICIENCY ANAEMIA 68 0.0074
593 BLADDER DISORDER 73 0.0073
594 DYSGEUSIA 546 0.0073
595 NAUSEA 5803 0.0073
596 HEPATIC STEATOSIS 136 0.0073
597 BLOOD PRESSURE ABNORMAL 145 0.0073
598 BLOOD THYROID STIMULATING HORMONE INCREASED 67 0.0073
599 HEPATITIS 186 0.0073
600 EAR INFECTION 193 0.0072
601 INTERVERTEBRAL DISC PROTRUSION 158 0.0072
602 FOOT FRACTURE 137 0.0072
603 HYPERSOMNIA 207 0.0072
604 HEPATIC ENZYME INCREASED 491 0.0072
605 PARAESTHESIA 1128 0.0072
606 LETHARGY 412 0.0072
607 PYELONEPHRITIS 62 0.0071
608 VENTRICULAR TACHYCARDIA 118 0.0071
609 ARTHROPATHY 397 0.0071
610 DECREASED IMMUNE RESPONSIVENESS 70 0.0071
611 FALL 2367 0.0071
612 SCIATICA 113 0.0071
613 NECK PAIN 396 0.0071
614 EOSINOPHILIA 124 0.0071
615 PLATELET COUNT INCREASED 92 0.0070
616 TRANSIENT ISCHAEMIC ATTACK 238 0.0070
617 RASH ERYTHEMATOUS 337 0.0070
618 DIALYSIS 100 0.0070
619 URINARY INCONTINENCE 207 0.0070
620 LIGAMENT SPRAIN 69 0.0070
621 URINARY RETENTION 232 0.0069
622 CARDIAC FAILURE 558 0.0069
623 EYE SWELLING 258 0.0069
624 ANKLE FRACTURE 107 0.0069
625 NEPHROLITHIASIS 316 0.0069
626 NEOPLASM 79 0.0069
627 EATING DISORDER 146 0.0068
628 FEEDING DISORDER 139 0.0068
629 ADRENAL INSUFFICIENCY 83 0.0068
630 HYPERCHOLESTEROLAEMIA 66 0.0068
631 FACE OEDEMA 115 0.0068
632 LACERATION 64 0.0068
633 WEIGHT DECREASED 1889 0.0068
634 RETINAL DETACHMENT 62 0.0067
635 ABDOMINAL DISTENSION 702 0.0067
636 NERVE COMPRESSION 62 0.0067
637 VITREOUS FLOATERS 66 0.0067
638 OSTEOARTHRITIS 284 0.0067
639 POOR QUALITY SLEEP 144 0.0067
640 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 349 0.0067
641 BURNING SENSATION 469 0.0067
642 CYST 83 0.0067
643 INTESTINAL PERFORATION 75 0.0067
644 ANOREXIA 86 0.0067
645 GASTRIC DISORDER 229 0.0067
646 CARDIAC FAILURE CONGESTIVE 534 0.0066
647 OXYGEN SATURATION DECREASED 373 0.0066
648 CARDIOMYOPATHY 98 0.0066
649 THYROID DISORDER 102 0.0066
650 HEART RATE IRREGULAR 149 0.0066
651 UNRESPONSIVE TO STIMULI 170 0.0066
652 DIPLOPIA 171 0.0066
653 DRUG LEVEL DECREASED 67 0.0066
654 DECREASED ACTIVITY 71 0.0066
655 UPPER LIMB FRACTURE 131 0.0066
656 HERNIA 127 0.0066
657 MUSCULOSKELETAL DISORDER 125 0.0066
658 PRODUCT DOSE OMISSION 428 0.0065
659 HYPERTENSION 1386 0.0065
660 UPPER GASTROINTESTINAL HAEMORRHAGE 110 0.0065
661 INSOMNIA 1736 0.0065
662 DYSPNOEA 3689 0.0065
663 DISEASE RECURRENCE 310 0.0065
664 JAUNDICE 175 0.0065
665 PULMONARY HYPERTENSION 135 0.0065
666 DYSPHAGIA 615 0.0065
667 PRESYNCOPE 157 0.0065
668 LACRIMATION INCREASED 195 0.0064
669 HEMIPARESIS 109 0.0064
670 INCONTINENCE 68 0.0064
671 CHEST DISCOMFORT 658 0.0064
672 DYSPEPSIA 631 0.0064
673 HAEMATOMA 166 0.0064
674 PANCREATITIS ACUTE 144 0.0064
675 VOMITING 3009 0.0064
676 SHOCK 147 0.0064
677 WHEEZING 379 0.0064
678 POOR VENOUS ACCESS 66 0.0064
679 GASTROINTESTINAL DISORDER 569 0.0063
680 SWELLING 594 0.0063
681 CHOLELITHIASIS 207 0.0063
682 VISION BLURRED 866 0.0063
683 LUNG DISORDER 309 0.0063
684 DYSPHONIA 368 0.0063
685 MOTOR DYSFUNCTION 64 0.0063
686 ABDOMINAL PAIN 1460 0.0063
687 DRUG-INDUCED LIVER INJURY 196 0.0062
688 EMPHYSEMA 63 0.0062
689 CORONARY ARTERY DISEASE 189 0.0062
690 GASTRIC ULCER 118 0.0062
691 ABDOMINAL DISCOMFORT 1041 0.0062
692 MALIGNANT MELANOMA 83 0.0062
693 METABOLIC ACIDOSIS 198 0.0062
694 FLATULENCE 351 0.0062
695 CHEST PAIN 1146 0.0062
696 AMNESIA 402 0.0062
697 MUSCLE TIGHTNESS 100 0.0062
698 PARAESTHESIA ORAL 89 0.0062
699 BLOOD TRIGLYCERIDES INCREASED 109 0.0062
700 APHONIA 86 0.0062
701 ABSCESS 98 0.0061
702 GENERAL PHYSICAL HEALTH DETERIORATION 706 0.0061
703 THERAPY INTERRUPTED 435 0.0061
704 EYE DISORDER 200 0.0061
705 DEAFNESS 159 0.0061
706 GLAUCOMA 116 0.0060
707 KIDNEY INFECTION 118 0.0060
708 DRUG INTOLERANCE 577 0.0060
709 DIZZINESS 2972 0.0060
710 HAEMATEMESIS 151 0.0060
711 FAECES DISCOLOURED 129 0.0059
712 RESTLESS LEGS SYNDROME 108 0.0059
713 CARDIAC ARREST 490 0.0059
714 BURSITIS 72 0.0059
715 MYOCARDITIS 68 0.0059
716 INTERSTITIAL LUNG DISEASE 287 0.0059
717 PRODUCT DOSE OMISSION ISSUE 1729 0.0059
718 COORDINATION ABNORMAL 82 0.0059
719 VERTIGO 357 0.0059
720 DYSSTASIA 171 0.0059
721 PRURITUS 2247 0.0058
722 ILLNESS 602 0.0058
723 AGITATION 429 0.0058
724 RESTLESSNESS 213 0.0058
725 DRY MOUTH 472 0.0058
726 DEATH 5009 0.0058
727 SENSORY DISTURBANCE 93 0.0058
728 MICTURITION URGENCY 66 0.0058
729 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 317 0.0058
730 SPEECH DISORDER 301 0.0057
731 ABDOMINAL PAIN UPPER 1179 0.0057
732 OSTEONECROSIS 188 0.0057
733 HALLUCINATION 430 0.0057
734 NASAL CONGESTION 335 0.0057
735 MACULAR DEGENERATION 68 0.0057
736 DRUG INTERACTION 903 0.0057
737 JOINT SWELLING 687 0.0057
738 BRONCHOSPASM 81 0.0057
739 FEELING JITTERY 108 0.0057
740 SKIN EXFOLIATION 478 0.0057
741 HEAD INJURY 179 0.0057
742 WOUND 158 0.0056
743 EYE HAEMORRHAGE 75 0.0056
744 MEMORY IMPAIRMENT 772 0.0056
745 MUSCLE ATROPHY 71 0.0056
746 ANOSMIA 81 0.0056
747 TINNITUS 257 0.0056
748 GAIT DISTURBANCE 1070 0.0056
749 QUALITY OF LIFE DECREASED 75 0.0056
750 NEOPLASM PROGRESSION 194 0.0056
751 IMPAIRED HEALING 183 0.0056
752 PHOTOSENSITIVITY REACTION 92 0.0056
753 HIATUS HERNIA 72 0.0056
754 PSYCHOMOTOR HYPERACTIVITY 92 0.0055
755 HEART RATE INCREASED 548 0.0055
756 BONE DENSITY DECREASED 173 0.0055
757 SCAR 94 0.0055
758 BLOOD PRESSURE SYSTOLIC INCREASED 107 0.0055
759 HEADACHE 3436 0.0055
760 ELECTROCARDIOGRAM QT PROLONGED 196 0.0054
761 JOINT RANGE OF MOTION DECREASED 73 0.0054
762 FEELING HOT 329 0.0054
763 HEAD DISCOMFORT 95 0.0054
764 MUSCULOSKELETAL DISCOMFORT 92 0.0053
765 DRY SKIN 712 0.0053
766 HOSPITALISATION 818 0.0053
767 MELAENA 117 0.0053
768 PARALYSIS 76 0.0053
769 HAEMATOCHEZIA 293 0.0053
770 GAIT INABILITY 176 0.0053
771 BLOOD PRESSURE DECREASED 349 0.0052
772 SOMNOLENCE 1056 0.0052
773 PAIN IN EXTREMITY 1542 0.0052
774 INSURANCE ISSUE 80 0.0052
775 COMA 249 0.0052
776 CONDITION AGGRAVATED 1583 0.0052
777 CONVULSION 297 0.0052
778 MYELOSUPPRESSION 187 0.0052
779 GASTROINTESTINAL HAEMORRHAGE 433 0.0052
780 MULTIPLE FRACTURES 85 0.0052
781 BLOOD CHOLESTEROL INCREASED 241 0.0052
782 HAIR TEXTURE ABNORMAL 69 0.0052
783 CEREBRAL INFARCTION 126 0.0052
784 ACUTE MYOCARDIAL INFARCTION 152 0.0051
785 LIP SWELLING 171 0.0051
786 INCREASED APPETITE 98 0.0051
787 URTICARIA 859 0.0051
788 PRODUCT DOSE OMISSION IN ERROR 145 0.0051
789 LOSS OF CONSCIOUSNESS 656 0.0051
790 MYALGIA 869 0.0051
791 ARRHYTHMIA 242 0.0051
792 WEIGHT INCREASED 1136 0.0051
793 CARDIO-RESPIRATORY ARREST 212 0.0051
794 FEMUR FRACTURE 157 0.0051
795 BLOOD PRESSURE INCREASED 774 0.0051
796 ABDOMINAL PAIN LOWER 128 0.0051
797 SKIN REACTION 71 0.0050
798 INTENTIONAL PRODUCT USE ISSUE 439 0.0050
799 ULCER 79 0.0050
800 MENTAL IMPAIRMENT 120 0.0049
801 MUSCULOSKELETAL PAIN 259 0.0049
802 ERYTHEMA 1016 0.0049
803 RECTAL HAEMORRHAGE 212 0.0049
804 MALAISE 2163 0.0049
805 PAIN 3023 0.0049
806 INTERNATIONAL NORMALISED RATIO INCREASED 140 0.0049
807 INFLAMMATION 253 0.0049
808 SEIZURE 562 0.0049
809 SKIN HAEMORRHAGE 72 0.0049
810 FEELING ABNORMAL 1164 0.0049
811 ANXIETY 1375 0.0048
812 EYE IRRITATION 276 0.0048
813 DERMATITIS 100 0.0048
814 OCULAR HYPERAEMIA 226 0.0048
815 IRRITABLE BOWEL SYNDROME 102 0.0048
816 INTESTINAL OBSTRUCTION 179 0.0047
817 PRODUCT USE IN UNAPPROVED INDICATION 1172 0.0047
818 PRODUCT PRESCRIBING ISSUE 103 0.0047
819 ARTHRALGIA 1957 0.0047
820 ARTHRITIS 370 0.0047
821 HYPERHIDROSIS 605 0.0047
822 BLOOD CREATINE PHOSPHOKINASE INCREASED 135 0.0047
823 THROAT IRRITATION 210 0.0047
824 CARDIOGENIC SHOCK 67 0.0047
825 PANCREATITIS 246 0.0046
826 MALIGNANT NEOPLASM PROGRESSION 474 0.0046
827 FLUSHING 468 0.0046
828 ERUCTATION 89 0.0046
829 RETCHING 98 0.0046
830 COLD SWEAT 81 0.0046
831 CIRCULATORY COLLAPSE 78 0.0046
832 DIABETES MELLITUS 348 0.0046
833 NERVOUSNESS 238 0.0046
834 EPILEPSY 139 0.0045
835 JOINT INJURY 97 0.0045
836 ADVERSE EVENT 418 0.0045
837 PERICARDITIS 76 0.0045
838 MUSCULOSKELETAL STIFFNESS 395 0.0045
839 SLEEP DISORDER 318 0.0045
840 SNEEZING 101 0.0045
841 DEPRESSION 1019 0.0045
842 DEMENTIA 125 0.0045
843 TENDONITIS 69 0.0045
844 INTENTIONAL DOSE OMISSION 127 0.0045
845 PALLOR 121 0.0044
846 DELUSION 69 0.0044
847 ISCHAEMIC STROKE 79 0.0044
848 BLOOD PRESSURE FLUCTUATION 106 0.0044
849 HOT FLUSH 331 0.0044
850 TOOTH LOSS 91 0.0044
851 PRODUCT USE COMPLAINT 69 0.0044
852 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 102 0.0044
853 HYPOACUSIS 188 0.0044
854 THIRST 78 0.0044
855 COLON CANCER 65 0.0044
856 LOCAL SWELLING 76 0.0044
857 IMPAIRED QUALITY OF LIFE 62 0.0043
858 JOINT STIFFNESS 113 0.0043
859 MUSCLE TWITCHING 99 0.0043
860 PALPITATIONS 501 0.0043
861 HAEMORRHAGE 447 0.0043
862 CEREBROVASCULAR ACCIDENT 722 0.0043
863 PULMONARY FIBROSIS 81 0.0042
864 RHABDOMYOLYSIS 176 0.0042
865 VISUAL IMPAIRMENT 522 0.0042
866 BONE LOSS 63 0.0042
867 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 298 0.0042
868 BLOOD GLUCOSE ABNORMAL 77 0.0042
869 LOWER LIMB FRACTURE 80 0.0042
870 PRURITUS GENERALISED 90 0.0042
871 HALLUCINATION, AUDITORY 66 0.0041
872 BLINDNESS 168 0.0041
873 TREATMENT NONCOMPLIANCE 225 0.0041
874 MOOD ALTERED 112 0.0041
875 ASTHMA 459 0.0041
876 DYSKINESIA 165 0.0041
877 ABASIA 100 0.0040
878 FREQUENT BOWEL MOVEMENTS 109 0.0040
879 MIDDLE INSOMNIA 75 0.0040
880 PRODUCT AVAILABILITY ISSUE 91 0.0040
881 ALOPECIA 783 0.0040
882 DISTURBANCE IN ATTENTION 215 0.0040
883 ANGINA PECTORIS 114 0.0040
884 SWOLLEN TONGUE 124 0.0040
885 PRODUCT USE ISSUE 745 0.0040
886 POST PROCEDURAL COMPLICATION 76 0.0040
887 HYPERSENSITIVITY 734 0.0040
888 INFLUENZA LIKE ILLNESS 323 0.0039
889 PRESCRIBED UNDERDOSE 77 0.0039
890 THINKING ABNORMAL 71 0.0038
891 THROAT TIGHTNESS 103 0.0038
892 FRACTURE 72 0.0038
893 GLOSSODYNIA 85 0.0038
894 VISUAL ACUITY REDUCED 126 0.0038
895 MOBILITY DECREASED 272 0.0038
896 ABNORMAL BEHAVIOUR 147 0.0037
897 LIVER INJURY 91 0.0037
898 DRUG INEFFECTIVE 4878 0.0037
899 SEROTONIN SYNDROME 71 0.0037
900 THERAPY CESSATION 187 0.0036
901 MIGRAINE 347 0.0036
902 MULTIPLE SCLEROSIS RELAPSE 248 0.0036
903 ANGIOEDEMA 160 0.0036
904 EYE PRURITUS 121 0.0036
905 SKIN FISSURES 70 0.0036
906 SURGERY 209 0.0036
907 INJURY 250 0.0036
908 ROAD TRAFFIC ACCIDENT 147 0.0035
909 NEOPLASM MALIGNANT 234 0.0035
910 PAIN OF SKIN 94 0.0035
911 PERITONITIS 71 0.0034
912 ERECTILE DYSFUNCTION 88 0.0034
913 HEPATIC CIRRHOSIS 64 0.0034
914 DRUG DOSE OMISSION 563 0.0034
915 ILL-DEFINED DISORDER 206 0.0034
916 PANIC ATTACK 123 0.0034
917 LACTIC ACIDOSIS 109 0.0034
918 EMOTIONAL DISTRESS 398 0.0033
919 PSYCHOTIC DISORDER 97 0.0033
920 PRESCRIBED OVERDOSE 63 0.0033
921 DISCOMFORT 198 0.0032
922 EMOTIONAL DISORDER 99 0.0032
923 IRRITABILITY 193 0.0032
924 TREATMENT FAILURE 265 0.0032
925 TOXICITY TO VARIOUS AGENTS 532 0.0032
926 CARDIOVASCULAR DISORDER 80 0.0031
927 PHARMACEUTICAL PRODUCT COMPLAINT 81 0.0031
928 MOVEMENT DISORDER 100 0.0031
929 MENTAL DISORDER 135 0.0031
930 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 557 0.0031
931 TYPE 2 DIABETES MELLITUS 104 0.0031
932 DEPRESSED MOOD 163 0.0031
933 PRODUCT PHYSICAL ISSUE 62 0.0031
934 PRODUCT PRESCRIBING ERROR 73 0.0031
935 MOOD SWINGS 97 0.0030
936 ANAPHYLACTIC REACTION 168 0.0030
937 MYOCARDIAL INFARCTION 530 0.0030
938 ACCIDENTAL OVERDOSE 111 0.0030
939 MULTIPLE SCLEROSIS 142 0.0030
940 THERAPEUTIC RESPONSE UNEXPECTED 133 0.0030
941 ECZEMA 155 0.0030
942 DRUG EXPOSURE DURING PREGNANCY 97 0.0028
943 PROCEDURAL PAIN 78 0.0028
944 AGGRESSION 140 0.0028
945 THERAPEUTIC RESPONSE DECREASED 165 0.0027
946 BLOOD GLUCOSE INCREASED 511 0.0027
947 RESPIRATORY ARREST 74 0.0027
948 THERAPEUTIC PRODUCT EFFECT DECREASED 120 0.0027
949 NIGHTMARE 92 0.0027
950 HYPOGLYCAEMIA 125 0.0026
951 CRYING 93 0.0026
952 PREMATURE BABY 77 0.0026
953 MEDICATION ERROR 139 0.0025
954 ABNORMAL DREAMS 69 0.0025
955 DRUG ADMINISTRATION ERROR 75 0.0024
956 EXPOSURE DURING PREGNANCY 151 0.0024
957 SYSTEMIC LUPUS ERYTHEMATOSUS 80 0.0023
958 VAGINAL HAEMORRHAGE 96 0.0022
959 FOETAL EXPOSURE DURING PREGNANCY 176 0.0022
960 ACNE 161 0.0021
961 MATERNAL EXPOSURE DURING PREGNANCY 189 0.0021
962 SUICIDAL IDEATION 192 0.0021
963 COLITIS ULCERATIVE 90 0.0020
964 ANGER 68 0.0020
965 BLOOD GLUCOSE DECREASED 96 0.0020
966 INCORRECT DOSE ADMINISTERED 450 0.0020
967 PRODUCT SUBSTITUTION ISSUE 108 0.0019
968 LUNG NEOPLASM MALIGNANT 77 0.0019
969 SKIN IRRITATION 83 0.0018
970 DRUG EFFECT DECREASED 94 0.0017
971 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 122 0.0017
972 SKIN BURNING SENSATION 119 0.0017
973 DERMATITIS ATOPIC 86 0.0016
974 PRODUCT QUALITY ISSUE 208 0.0015
975 OVERDOSE 329 0.0015
976 ABORTION SPONTANEOUS 61 0.0015
977 INJECTION SITE REACTION 104 0.0015
978 INJECTION SITE PRURITUS 99 0.0015
979 INTENTIONAL PRODUCT MISUSE 128 0.0015
980 INJECTION SITE ERYTHEMA 169 0.0014
981 PSORIASIS 174 0.0013
982 RHEUMATOID ARTHRITIS 148 0.0013
983 NO ADVERSE EVENT 230 0.0013
984 SUICIDE ATTEMPT 75 0.0012
985 PROSTATE CANCER 93 0.0012
986 UNDERDOSE 81 0.0011
987 INJECTION SITE SWELLING 81 0.0011
988 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 212 0.0010
989 BREAST CANCER 97 0.0010
990 COMPLETED SUICIDE 83 0.0010
991 INJECTION SITE BRUISING 79 0.0010
992 INJECTION SITE PAIN 258 0.0008
993 DRUG WITHDRAWAL SYNDROME 64 0.0007
994 DEVICE ISSUE 64 0.0007
995 ACCIDENTAL EXPOSURE TO PRODUCT 63 0.0006